AI assistant
Sending…
Phathom Pharmaceuticals, Inc. — Director's Dealing 2025
Nov 5, 2025
32407_dirs_2025-11-05_0ea27b01-4042-42f1-9081-6d9fb00177de.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2025-11-03
Reporting Person: Breedlove Robert Charles (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-03 | Common Stock | S | 524 | $13.51 | Disposed | 47407 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6945.4 | Indirect |
Footnotes
F1: Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
More from Phathom Pharmaceuticals, Inc.
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 12